Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Katsumoto, Eiichi"" wg kryterium: Autor


Wyświetlanie 1-15 z 15
Tytuł :
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder
Autorzy :
Tokumitsu, Keita
Yasui-Furukori, NorioAff1, Aff2
Adachi, Naoto
Kubota, Yukihisa
Watanabe, Yoichiro
Miki, Kazuhira
Azekawa, Takaharu
Edagawa, Koji
Katsumoto, Eiichi
Hongo, Seiji
Goto, Eiichiro
Ueda, Hitoshi
Kato, MasakiAff2, Aff4
Yoshimura, ReijiAff2, Aff5
Nakagawa, AtsuoAff2, Aff6
Kikuchi, ToshiakiAff2, Aff6
Tsuboi, TakashiAff2, Aff7
Shimoda, Kazutaka
Watanabe, KoichiroAff2, Aff7
Pokaż więcej
Źródło :
BMC Psychiatry. 20(1)
Czasopismo naukowe
Tytuł :
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study.
Autorzy :
Adachi, Naoto
Azekawa, Takaharu
Edagawa, Kouji
Goto, Eiichiro
Hongo, Seiji
Kato, Masaki
Katsumoto, Eiichi
Kikuchi, Toshiaki
Kubota, Yukihisa
Miki, Kazuhira
Nakagawa, Atsuo
Tsuboi, Takashi
Ueda, Hitoshi
Watanabe, Koichiro
Watanabe, Yoichiro
Yasui‐Furukori, Norio
Yoshimura, Reiji
Pokaż więcej
Temat :
BIPOLAR disorder
CLINICS
SOCIAL adjustment
POLYPHARMACY
ARIPIPRAZOLE
PSYCHIATRIC drugs
MULTIPLE regression analysis
PSYCHIATRIC clinics
Źródło :
Human Psychopharmacology: Clinical & Experimental; Mar2021, Vol. 36 Issue 2, p1-8, 8p
Terminy geograficzne :
JAPAN
Czasopismo naukowe
Tytuł :
Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Autorzy :
Ichihashi, Kayo
Hori, Hikaru
Hasegawa, Naomi
Yasuda, Yuka
Yamamoto, Tomoya
Tsuboi, Takashi
Iwamoto, Kunihiro
Kishimoto, Taishiro
Horai, Tadasu
Yamada, Hiroki
Sugiyama, Nobuhiro
Nakamura, Toshinori
Tsujino, Naohisa
Nemoto, Kiyotaka
Oishi, Satoru
Usami, Masahide
Katsumoto, Eiichi
Yamamori, Hidenaga
Tomita, Hiroaki
Suwa, Taro
Pokaż więcej
Temat :
PSYCHIATRIC treatment
PSYCHIATRY education
AMISULPRIDE
SCHIZOPHRENICS
PSYCHIATRIC drugs
MOOD stabilizers
Źródło :
Neuropsychopharmacology Reports; Sep2020, Vol. 40 Issue 3, p281-286, 6p
Terminy geograficzne :
JAPAN
Czasopismo naukowe
Tytuł :
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
Autorzy :
Numata S; Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Nakataki M; Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Hasegawa N; Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Takaesu Y; Department of Neuropsychiatry, School of Medicine, Kyorin University, Tokyo, Japan.
Takeshima M; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
Onitsuka T; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nakamura T; Department of Psychiatry, Shinshu University School of Medicine, Nagano, Japan.
Edagawa R; Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Edo H; Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Miura K; Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Matsumoto J; Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Yasui-Furukori N; Department of Psychiatry, School of Medicine, Dokkyo Medical University, Tochigi, Japan.
Kishimoto T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Hori H; Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Tsuboi T; Department of Neuropsychiatry, School of Medicine, Kyorin University, Tokyo, Japan.
Yasuda Y; Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.; Medical Corporation Foster, Osaka, Japan.
Furihata R; Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.; Kyoto University Health Service, Kyoto, Japan.
Muraoka H; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
Ochi S; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
Nagasawa T; Department of NeuroPsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Kyou Y; Department of Psychiatry, School of Medicine, Kitasato University, Kanagawa, Japan.
Murata A; Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Katsumoto E; Katsumoto Mental Clinic, Osaka, Japan.
Ohi K; Department of Psychiatry and Psychotherapy, Gifu University Graduate School of Medicine, Gifu, Japan.
Hishimoto A; Department of Psychiatry, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Inada K; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
Watanabe K; Department of Neuropsychiatry, School of Medicine, Kyorin University, Tokyo, Japan.
Hashimoto R; Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Pokaż więcej
Źródło :
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2021 Mar 11. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Yokukansankachimpihange Is Useful to Treat Behavioral/Psychological Symptoms of Dementia.
Autorzy :
Katsumoto E; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Katsumoto Mental Clinic, Osaka, Japan.
Ishida T; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Ishida Clinic, Osaka, Japan.
Kinoshita K; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Kinoshita Clinic, Osaka, Japan.
Shimizu M; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Shimizu Clinic, Osaka, Japan.
Tsutsumi T; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Tsutsumi Clinic, Osaka, Japan.
Nagai Y; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Nagai Clinic, Osaka, Japan.
Nishimura M; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Nishimura Clinic, Osaka, Japan.
Yokouchi T; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Yokouchi Clinic, Osaka, Japan.
Yoshida Y; Osaka Association of Psychiatric Clinics, Osaka, Japan.; Yoshida Clinic, Osaka, Japan.
Pokaż więcej
Źródło :
Frontiers in nutrition [Front Nutr] 2021 Jan 21; Vol. 7, pp. 529390. Date of Electronic Publication: 2021 Jan 21 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Autorzy :
Iida H; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Iga J; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
Hasegawa N; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Yasuda Y; Medical Corporation Foster, Osaka, Japan.
Yamamoto T; Department of Pharmacy, Osaka University Hospital, Osaka, Japan.
Miura K; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Matsumoto J; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Murata A; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Ogasawara K; Center for Postgraduate Clinical Training and Career Development, Nagoya University Hospital, Aichi, Japan.
Yamada H; Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan.
Hori H; Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Ichihashi K; Deaprtment of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan.
Hashimoto N; Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
Ohi K; Department of Psychiatry and Psychotherapy, Gifu University Graduate School of Medicine, Gifu, Japan.
Yasui-Furukori N; Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Tsuboi T; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Nakamura T; Department of Psychiatry, Shinshu University School of Medicine, Nagano, Japan.
Usami M; Department of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba, Japan.
Furihata R; Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.
Takaesu Y; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Iwamoto K; Department of Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan.
Sugiyama N; Department of Applied Occupational Therapy, Shinshu University School of Health Sciences, Nagano, Japan.
Kishimoto T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Tsujino N; Department of Neuropsychiatry, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan.
Yamada H; Department of Psychiatry, Showa University Northern Yokohama Hospital, Kanagawa, Japan.
Hishimoto A; Department of Psychiatry, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Nemoto K; Department of Psychiatry, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Atake K; Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Muraoka H; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
Katsumoto E; Katsumoto Mental Clinic, Osaka, Japan.
Oishi S; Department of Psychiatry, Kitasato University School of Medicine, Kanagawa, Japan.
Inagaki T; Adolescent Mental Health Service, Biwako Hospital, Shiga, Japan.
Ito F; Department of Psychiatry, Tohoku University Hospital, Miyagi, Japan.
Imamura Y; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Kido M; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Nagasawa T; Department of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Numata S; Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Ochi S; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
Iwata M; Department of Neuropsychiatry, Faculty of Medicine, Tottori University, Tottori, Japan.
Yamamori H; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Fujita J; Department of Psychiatry, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Onitsuka T; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yamamura S; Suzuka Kosei Hospital, Mie, Japan.
Makinodan M; Department of Psychiatry, Nara Medical University School of Medicine, Nara, Japan.
Fujimoto M; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Takayanagi Y; Department of Neuropsychiatry, University of Toyama School of Medicine, Toyama, Japan.
Takezawa K; Medical Corporation Matsuzaki Hospital, Toyohashi Mental Care Center, Aichi, Japan.
Komatsu H; Department of Psychiatry, Tohoku University Hospital, Miyagi, Japan.
Fukumoto K; Department of Neuropsychiatry, Iwate Medical University, Iwate, Japan.
Tamai S; Department of Neuropsychiatry, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Yamagata H; Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University School of Medicine, Yamaguchi, Japan.
Kubota C; Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Horai T; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
Inada K; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
Watanabe K; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Kawasaki H; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Hashimoto R; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Pokaż więcej
Źródło :
Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2020 Dec; Vol. 74 (12), pp. 667-669. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Letter
Opinia redakcyjna
    Wyświetlanie 1-15 z 15

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies